Scarica l'app Stockscreener
0.2541
10.62%
-0.0302
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.2843
Aprire:
$0.2749
Volume 24 ore:
1.28M
Relative Volume:
1.45
Capitalizzazione di mercato:
$13.30M
Reddito:
$65.27M
Utile/perdita netta:
$-19.15M
Rapporto P/E:
-0.4093
EPS:
-0.6208
Flusso di cassa netto:
$-12.43M
1 W Prestazione:
-17.07%
1M Prestazione:
-27.13%
6M Prestazione:
-62.50%
1 anno Prestazione:
-46.03%
Intervallo 1D:
$0.2464
$0.2749
Intervallo di 1 settimana:
$0.2464
$0.3083
Portata 52W:
$0.2464
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Nome
Cosmos Health Inc
Settore
Industria
Telefono
312-536-3102
Indirizzo
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.2541 | 14.88M | 65.27M | -19.15M | -12.43M | -0.6208 |
MCK
Mckesson Corp
|
758.50 | 90.72B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
263.48 | 51.51B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
200.00 | 46.66B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
73.31 | 8.34B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.54 | 1.37B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc Borsa (COSM) Ultime notizie
Cosmos Health (COSM) Reports Strong Q1 2026 Revenue Growth - GuruFocus
Cosmos Health reports Q1 revenue of $17.9M, up 31% year-over-year - Investing.com
Cosmos Health trims $4.5M debt, eyes U.S. nutraceuticals push after record Q1 - Stock Titan
Cosmos Health Inc. 1Q 2026: Revenue $17.93M, EPS ($0.06) — 10-Q Summary - TradingView
Cosmos Health (NASDAQ: COSM) posts Q1 loss and issues going‑concern warning - Stock Titan
Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt P - ACCESS Newswire
Cosmos Health Company Profile & Introduction - Moomoo
COSM Q1'26 Earnings: EPS estimate is (0.01) USD - TradingView
Cosmos Health Inc stock (US22143K1016): volatility after reverse split and uplisting plans draw inve - AD HOC NEWS
Cosmos Health Inc.Common Stock (NQ: COSM - FinancialContent
[NT 10-Q] Cosmos Health Inc. SEC Filing - Stock Titan
Cosmos Health (COSM) Engages European Investment Bank for R&D Fi - GuruFocus
Cosmos Health stock (US22143K1016): Pursues €25M EIB financing for R&D - AD HOC NEWS
Cosmos Health pursues €25M EIB financing for R&D program By Investing.com - Investing.com South Africa
Cosmos Health pursues €25M EIB financing for R&D program - Investing.com
EU bank review could unlock €25M for Cosmos Health drug R&D - Stock Titan
Cosmos Health regains compliance with Nasdaq’s listing rule - MSN
Cosmos Health (COSM) Withdraws Registration Statement for Public Offering - GuruFocus
TradingKey - TradingKey
Cosmos Health stock (US22143K1016): Fort18 launch targets $3.2M revenue boost - AD HOC NEWS
Cosmos Health withdraws SEC registration statement - Investing.com UK
Cosmos Health withdraws SEC registration statement By Investing.com - Investing.com South Africa
Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 - ACCESS Newswire
Cosmos Health scraps public offering, pulls SEC registration - Stock Titan
Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months - Digital Journal
[RW] Cosmos Health Inc. SEC Filing - Stock Titan
Men's stamina supplement Fort18 targets $3.2M U.S. sales - Stock Titan
Cosmos Health Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
COSM introduces new product for sexual health - MSN
Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed - ACCESS Newswire
Cosmos Health(COSM) Stock Options Chain | Quotes & News - Moomoo
Cosmos Health Introduces the "18 Series" in the United StatesA Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products - Quantisnow
COSM Stock Price, Quote & Chart | COSMOS HEALTH INC (NASDAQ:COSM) - ChartMill
Number of shareholders of Cosmos Health Inc. – NASDAQ:COSM - TradingView
Cosmos Health launches Fort18 men’s wellness supplement in U.S. By Investing.com - Investing.com Australia
Cosmos Health launches Fort18 men’s wellness supplement in U.S. - Investing.com UK
Cosmos Health Introduces Fort18 in the United StatesA Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness - ACCESS Newswire
Cosmos Health enters men's wellness as U.S. market heads to $1.93B - Stock Titan
Cosmos Health (COSM) price target increased by 50.00% to 4.59 - MSN
Cosmos Health (COSM) Projects Significant Revenue Growth with Cu - GuruFocus
Cosmos Health Inc Azioni (COSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cosmos Health Inc Azioni (COSM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
| Siokas Grigorios | Chief Executive Officer |
Jan 06 '26 |
Buy |
0.54 |
133,953 |
72,000 |
6,850,724 |
| Siokas Grigorios | Chief Executive Officer |
Dec 19 '25 |
Buy |
0.49 |
88,314 |
43,000 |
6,716,771 |
| Siokas Grigorios | Chief Executive Officer |
Dec 15 '25 |
Buy |
0.42 |
168,472 |
70,000 |
6,628,457 |
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):